Current price is less than the intrinsic value
Stock has been generating better return on equity than bank FD
Stock doesn't offer attractive dividend returns
Good time to consider, as stock is not in overbought zone
Stock not in ASM/GSM lists and not a lot of promoter holding is pledged
PE RatioPE Ratio | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
-6.82 | 1.11 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
38.16 | 4.82 | 0.92% |
Strides Pharma Science is a vertically integrated global pharmaceutical company engaged in the development and manufacturing of active pharmaceutical ingredients and formulations, as well as biotech
Customise key metrics, see detailed forecasts, download stock data and more
In last 6 months, promoter holding in the company has almost stayed constant
A significant proportion of promoter holdings is pledged
In last 3 months, mutual fund holding of the company has decreased by 2.57%
1 week ago•Bloomberg Quint
1 week ago•Economic Times
2 weeks ago•Business Standard
Strides Pharma Science Limited has informed the Exchange about press release dated 08-Aug-2022 titled Strides announces successful completion of US FDA inspection at its Singapore facility | Download
Strides Pharma Science Limited has informed the Exchange about press release dated 08-Aug-2022 titled Strides announces successful completion of US FDA inspection at its Singapore facility | Download
Final • Div/Share: ₹ 2.5
Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Current price is less than the intrinsic value